Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$nktrs Graphic](https://lunarcrush.com/gi/w:26/t:$nktrs.png) $nktrs

$NKTR sees a surge in social engagement amid discussions of potential damages from LLY and positive trial results. Users are anticipating a favorable outcome for NKTR's legal claims and drug development, with SNY's market cap dropping significantly.

### About $nktrs
Social media analysis of the stock ticker $nktrs.  

### Engagements: XX [#](/topic/$nktrs/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nktrs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXXXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-10-06  
**1-Year Low**: XX on 2025-07-10  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$nktrs/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nktrs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-09-10  
**1-Year Low**: X on 2025-06-27  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$nktrs/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nktrs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $nktrs in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-09-10  
**1-Year Low**: X on 2025-06-27  

The most influential creators that mention $nktrs in the last XX hours

| Creator                                | Rank | Followers | Posts | Engagements |
| -------                                | ---- | --------- | ----- | ----------- |
| [@A_May_MD](/creator/twitter/A_May_MD) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$nktrs/100)

**Top assets mentioned**
In the posts about $nktrs in the last XX hours

[Sanofi (SNY)](/topic/sanofi)
[Synthetify (SNY)](/topic/$sny)

**Top topics mentioned**
In the posts about $nktrs in the last XX hours

[sanofi](/topic/sanofi), [stocks healthcare](/topic/stocks-healthcare), [$sny](/topic/$sny), [$nktr](/topic/$nktr), [$122b](/topic/$122b), [$snys](/topic/$snys)

### Top Social Posts [#](/topic/$nktrs/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"And one more thing - I do hear the argument "well $SNY traded down because P3 efficacy got worse compared to P2. Couldn't the same thing happen to $NKTR" Sure it could but $SNY's efficacy decayed almost entirely due to higher placebo response rates in P3 compared to P2 jumping from XX% to 19%. $NKTR's P2b pbo rate was already XX% - just X points off of where $SNY's P3 ended up. $NKTR is in a *fantastic* spot to be able to reproduce a P3 EASI75 delta in the same range as their P2's was. If that happens this will be a biotech "phoenix from the ashes" story of the ages Last time I'll say it. I"  
[X Link](https://x.com/A_May_MD/status/1963715974495928523) [@A_May_MD](/creator/x/A_May_MD) 2025-09-04T21:29Z 17.5K followers, 40.1K engagements


"Final Numbers: $SNY down $12.2B $NKTR up $0.11B. $SNY lost 111x what $NKTR gained today. I'm a broken (and biased) record on $NKTR's valuation but seriously - why isn't this thing getting *any* respect for the size of the 2L+ atopic derm market and the P2b data they already have I feel like I'm going insane when I review all the data and market sizes here and ending up with this $700M valuation. It's similar to how I felt when I posted what I considered to be borderline mathematical proof that $ABVX was going to hit in P3 only for the stock to trade down a few cents over the next XX hours"  
[X Link](https://x.com/A_May_MD/status/1963715972331651194) [@A_May_MD](/creator/x/A_May_MD) 2025-09-04T21:29Z 17.5K followers, 75.7K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$nktrs Graphic $nktrs

$NKTR sees a surge in social engagement amid discussions of potential damages from LLY and positive trial results. Users are anticipating a favorable outcome for NKTR's legal claims and drug development, with SNY's market cap dropping significantly.

About $nktrs

Social media analysis of the stock ticker $nktrs.

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-10-06
1-Year Low: XX on 2025-07-10

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-27

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $nktrs in the last XX hours which is no change from in the previous XX hours Daily Average: X
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-27

The most influential creators that mention $nktrs in the last XX hours

Creator Rank Followers Posts Engagements
@A_May_MD X XXXXXX X XX

View More

Top assets mentioned In the posts about $nktrs in the last XX hours

Sanofi (SNY) Synthetify (SNY)

Top topics mentioned In the posts about $nktrs in the last XX hours

sanofi, stocks healthcare, $sny, $nktr, $122b, $snys

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"And one more thing - I do hear the argument "well $SNY traded down because P3 efficacy got worse compared to P2. Couldn't the same thing happen to $NKTR" Sure it could but $SNY's efficacy decayed almost entirely due to higher placebo response rates in P3 compared to P2 jumping from XX% to 19%. $NKTR's P2b pbo rate was already XX% - just X points off of where $SNY's P3 ended up. $NKTR is in a fantastic spot to be able to reproduce a P3 EASI75 delta in the same range as their P2's was. If that happens this will be a biotech "phoenix from the ashes" story of the ages Last time I'll say it. I"
X Link @A_May_MD 2025-09-04T21:29Z 17.5K followers, 40.1K engagements

"Final Numbers: $SNY down $12.2B $NKTR up $0.11B. $SNY lost 111x what $NKTR gained today. I'm a broken (and biased) record on $NKTR's valuation but seriously - why isn't this thing getting any respect for the size of the 2L+ atopic derm market and the P2b data they already have I feel like I'm going insane when I review all the data and market sizes here and ending up with this $700M valuation. It's similar to how I felt when I posted what I considered to be borderline mathematical proof that $ABVX was going to hit in P3 only for the stock to trade down a few cents over the next XX hours"
X Link @A_May_MD 2025-09-04T21:29Z 17.5K followers, 75.7K engagements

$nktrs
/topic/$nktrs